{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:13:38Z","timestamp":1771265618105,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Moyamoya-like vasculopathy (MMV) and myosin heavy chain 9-related platelet disorders (MYH9-RPDs) or macrothrombocitopenias are rare syndromes. Their association is even more infrequent.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 29-year-old female with history of MYH9-RPD, presented to our department for episodes suggesting transient ischemic attacks. Based on the imaging studies that revealed multiple ischemic lesions and stenoses of both distal internal carotid arteries and the arteries of the circle of Willis, the diagnosis of MMV was established. The treatment with Verapamil was initiated, leading to symptom remission. Two months later, the patient presented one episode of dysarthria, followed by involuntary movements of the right upper limb, few days later. Long-term electroencephalogram monitoring depicted epileptiform abnormalities. Resolution of symptoms was obtained after increasing the dose of Verapamil, and initiating Levetiracetam.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This is an interesting case of a patient with two rare pathologies, who presented with cerebral ischemic strokes. To our knowledge there are few cases described in the literature presenting with cerebral hemorrhagic events but none of them with multiple cerebral ischemic lesions. As these cases are very rare, it is important to gather evidence regarding the best approach and treatment strategy.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12883-020-01927-6","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T05:02:38Z","timestamp":1600491758000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Moyamoya-like vasculopathy associated to MYH9-related thrombocytopenia manifested by multiple cerebral ischemic lesions: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6200-2798","authenticated-orcid":false,"given":"Athena Cristina","family":"Ribigan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raluca Stefania","family":"Badea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alida","family":"Ciocan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Casaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Ioan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florina","family":"Antochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ovidiu","family":"B\u0103jenaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,19]]},"reference":[{"issue":"12","key":"1927_CR1","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1161\/STROKEAHA.107.513408","volume":"39","author":"M Kraemer","year":"2008","unstructured":"Kraemer M, Heienbrok W, Berlit P. Moyamoya disease in Europeans. Stroke. 2008;39(12):3193\u2013200.","journal-title":"Stroke."},{"issue":"6","key":"1927_CR2","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3340\/jkns.2015.57.6.408","volume":"57","author":"JH Phi","year":"2015","unstructured":"Phi JH, Wang KC, Lee JY, Kim SK. Moyamoya syndrome: a window of Moyamoya disease. J Korean Neurosurg Soc. 2015;57(6):408\u201314.","journal-title":"J Korean Neurosurg Soc"},{"issue":"2","key":"1927_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-0029-1220327","volume":"35","author":"K Althaus","year":"2009","unstructured":"Althaus K, Greinacher A. MYH9-related platelet disorders. Semin Thromb Hemost. 2009;35(2):189\u2013203.","journal-title":"Semin Thromb Hemost"},{"key":"1927_CR4","first-page":"49","volume":"8","author":"S Guey","year":"2015","unstructured":"Guey S, Tournier-Lasserve E, Herve D, Kossorotoff M. Moyamoya disease and syndromes: from genetics to clinical management. Appl Clin Genet. 2015;8:49\u201368.","journal-title":"Appl Clin Genet"},{"issue":"1","key":"1927_CR5","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.4081\/ni.2011.e3","volume":"3","author":"MA Lazzaro","year":"2011","unstructured":"Lazzaro MA, Cochran EJ, Lopes DK, Prabhakaran S. Moyamoya syndrome in an adult with essential thrombocythemia. Neurol Int. 2011;3(1):e3.","journal-title":"Neurol Int"},{"issue":"6","key":"1927_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00381-015-2619-4","volume":"31","author":"T Hayashi","year":"2015","unstructured":"Hayashi T, Akioka N, Kashiwazaki D, Kuwayama N, Kuroda S. Ischemic stroke in pediatric moyamoya disease associated with immune thrombocytopenia--a case report. Childs Nerv Syst. 2015;31(6):991\u20136.","journal-title":"Childs Nerv Syst"},{"issue":"5","key":"1927_CR7","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/NRL.0000000000000150","volume":"22","author":"Y Bejot","year":"2017","unstructured":"Bejot Y, Barnay JL, Chavent A, Daubail B, Jacquin A, Kazemi A, et al. Subarachnoid hemorrhage revealing Moyamoya syndrome in a patient with may-Hegglin anomaly. Neurologist. 2017;22(5):204\u20135.","journal-title":"Neurologist."},{"issue":"4","key":"1927_CR8","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11239-011-0623-4","volume":"32","author":"A Girolami","year":"2011","unstructured":"Girolami A, Vettore S, Bonamigo E, Fabris F. Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old may-Hegglin, Sebastian, Fechtner and Epstein syndromes). J Thromb Thrombolysis. 2011;32(4):474\u20137.","journal-title":"J Thromb Thrombolysis"},{"issue":"3\u20134","key":"1927_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1159\/000442298","volume":"41","author":"A Bersano","year":"2016","unstructured":"Bersano A, Guey S, Bedini G, Nava S, Herve D, Vajkoczy P, et al. Research progresses in understanding the pathophysiology of Moyamoya disease. Cerebrovasc Dis. 2016;41(3\u20134):105\u201318.","journal-title":"Cerebrovasc Dis"},{"key":"1927_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.nrl.2014.03.006","volume":"31","author":"CP Jim\u00e9nez","year":"2016","unstructured":"Jim\u00e9nez CP. Adult-onset moyamoya disease in a patient with neurofibromatosis type 1. Neurologia. 2016;31:139\u201341.","journal-title":"Neurologia."},{"key":"1927_CR11","first-page":"2591494","volume":"2018","author":"E Ilyayeva","year":"2018","unstructured":"Ilyayeva E, Nada K, Farahi Far R, Albright K, Gujral MK, Gold M. Bilateral cerebrovascular stroke as an initial presenting symptom of Moyamoya disease. Case Rep Crit Care. 2018;2018:2591494.","journal-title":"Case Rep Crit Care"},{"issue":"4","key":"1927_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4103\/jpgm.JPGM_468_17","volume":"64","author":"PN Doctor","year":"2018","unstructured":"Doctor PN, Choudhari A, Verma M, Merchant RH. Moyamoya syndrome in hemoglobin E-beta thalassemia: a rare presentation and association. J Postgrad Med. 2018;64(4):240\u20132.","journal-title":"J Postgrad Med"},{"issue":"4","key":"1927_CR13","first-page":"229","volume":"70","author":"T Hishikawa","year":"2016","unstructured":"Hishikawa T, Sugiu K, Date I. Moyamoya disease: a review of clinical research. Acta Med Okayama. 2016;70(4):229\u201336.","journal-title":"Acta Med Okayama"},{"issue":"1","key":"1927_CR14","first-page":"1070","volume":"3","author":"AZ Zuberi","year":"2016","unstructured":"Zuberi AZ, Ahmed BN, Iqbal S, Page S. May-Hegglin anomaly and the devastating consequences of acute cerebral hemispheric infarction. Ann Hematol Oncol. 2016;3(1):1070.","journal-title":"Ann Hematol Oncol"},{"issue":"2","key":"1927_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2141.2011.08716.x","volume":"154","author":"CL Balduini","year":"2011","unstructured":"Balduini CL, Pecci A, Savoia A. Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. Br J Haematol. 2011;154(2):161\u201374.","journal-title":"Br J Haematol"},{"issue":"4","key":"1927_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/ckj\/sfz103","volume":"12","author":"R Fernandez-Prado","year":"2019","unstructured":"Fernandez-Prado R, Carriazo-Julio SM, Torra R, Ortiz A, Perez-Gomez MV. MYH9-related disease: it does exist, may be more frequent than you think and requires specific therapy. Clin Kidney J. 2019;12(4):488\u201393.","journal-title":"Clin Kidney J"},{"issue":"1","key":"1927_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1055\/s-2005-868161","volume":"15","author":"GJ Zipfel","year":"2005","unstructured":"Zipfel GJ, Fox DJ Jr, Rivet DJ. Moyamoya disease in adults: the role of cerebral revascularization. Skull Base. 2005;15(1):27\u201341.","journal-title":"Skull Base"},{"issue":"12","key":"1927_CR18","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.030","volume":"27","author":"K Oki","year":"2018","unstructured":"Oki K, Katsumata M, Izawa Y, Takahashi S, Suzuki N, Houkin K, et al. Trends of antiplatelet therapy for the Management of Moyamoya Disease in Japan: results of a Nationwide survey. J Stroke Cerebrovasc Dis. 2018;27(12):3605\u201312.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"1","key":"1927_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1055\/s-2005-868160","volume":"15","author":"ER Smith","year":"2005","unstructured":"Smith ER, Scott RM. Surgical management of moyamoya syndrome. Skull Base. 2005;15(1):15\u201326.","journal-title":"Skull Base"},{"issue":"12","key":"1927_CR20","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1056\/NEJMra0804622","volume":"360","author":"RM Scott","year":"2009","unstructured":"Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226\u201337.","journal-title":"N Engl J Med"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01927-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-020-01927-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01927-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T23:05:34Z","timestamp":1632006334000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01927-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,19]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1927"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01927-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,19]]},"assertion":[{"value":"4 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The patient signed an informed consent concerning medical care and approval for confidential data access and processing, approved by the Hospital Ethics Committee F-562-18. Research was performed in accordance with the Declaration of Helsinki and GDPR standards.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}